Armata Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 3.44 USD (Oct 30, 2026, 9:30 AM EDT) · Market cap 127.91M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.